Cariprazine: A Review in Schizophrenia

Garnock-Jones, KP

Garnock-Jones, KP (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

CNS DRUGS, 2017; 31 (6): 513

Abstract

Cariprazine (VraylarT (TM)) is a dopamine D-3-preferring D2/D3 receptor partial agonist indicated for the treatment of patients with schizophrenia. Th......

Full Text Link